My Portfolio
My Watchlists
Profile & Performance
Smart Portfolio
Find & Follow Experts
Top Lists
Top Experts
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions, conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts.
About Us
Plans & Pricing
Kadmon Holdings (KDMN)
KDMN nasdaq
United States
Kadmon Holdings

Kadmon Holdings Stock Analysis & Ratings

Kadmon Holdings Stock Analysis Overview

Smart Score
Learn more about TipRanks Smart Score
The Kadmon Holdings stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.

Stock Chart


KDMN Stock Stats

Previous Close$8.87
Bid0 x 0
Ask0 x 0
Today’s Range$8.73 - $8.94
52-Week Range$3.15 - $9.20
Average Volume6.28M
Market Cap$1.54B
P/E Ratio-13.0
Earnings DateNov 11, 2021

Company Description

Kadmon Holdings

Kadmon Holdings, Inc. is a biopharmaceutical company, which engages in discovering, developing, and commercializing small molecules and biologics. It focuses on the treatment of autoimmune, inflammatory, and fibrotic diseases. Its products include Ribasphere, RibaPak, Tetrabenazine, Valganciclovir, Abacavir, Entecavir, Lamivudine, and Zidovudine. The company was founded by Steven N. Gordon in September 2010 and is headquartered in New York, NY.
Harlan W. Waksal
450 East 29th Street, New York, NY, 10016, US


P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


What was Kadmon Holdings’s price range in the past 12 months?
Kadmon Holdings lowest stock price was $3.15 and its highest was $9.20 in the past 12 months.
    What is Kadmon Holdings’s market cap?
    Kadmon Holdings’s market cap is $1.54B.
      What is Kadmon Holdings’s price target?
      The average price target for Kadmon Holdings is $11.50. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $20.00 ,the lowest forecast is $9.00. The average price target represents 31.73% Increase from the current price of $8.73.
        What do analysts say about Kadmon Holdings?
        Kadmon Holdings’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 6 Wall Streets Analysts.
          When is Kadmon Holdings’s upcoming earnings report date?
          Kadmon Holdings’s upcoming earnings report date is Nov 11, 2021 which is in 24 days.
            How were Kadmon Holdings’s earnings last quarter?
            Kadmon Holdings released its earnings results on Aug 05, 2021. The company reported -$0.18 earnings per share for the quarter, the consensus estimate of -$0.18 by $0.
              Is Kadmon Holdings overvalued?
              According to Wall Street analysts Kadmon Holdings’s price is currently Undervalued.
                Does Kadmon Holdings pay dividends?
                Kadmon Holdings does not currently pay dividends.
                What is Kadmon Holdings’s EPS estimate?
                Kadmon Holdings’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Kadmon Holdings have?
                Kadmon Holdings has 176,240,000 shares outstanding.
                  What happened to Kadmon Holdings’s price movement after its last earnings report?
                  Kadmon Holdings reported an EPS of -$0.18 in its last earnings report, expectations of -$0.18. Following the earnings report the stock price went up 8.261%.
                    Which hedge fund is a major shareholder of Kadmon Holdings?
                    Among the largest hedge funds holding Kadmon Holdings’s share is Perceptive Advisors LLC. It holds Kadmon Holdings’s shares valued at 61M.

                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis